US panel rejects Philip Morris claim iQOS tobacco device cuts disease risk
The panel concluded the company had not proven that the sleek, pen-like device reduces harm compared with cigarettes
Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the US Food and Drug Administration said on Thursday.
The panel concluded that Philip Morris had not proven that iQOS – a sleek, pen-like device that heats tobacco rather than burning it – reduces harm compared with cigarettes. The company’s shares were down 2.8% at $107.50 on Thursday afternoon after falling as much as 6.8%.Continue reading...